Fig. 1: Impact of conditioning by FluMel and FluTreo on outcome. | Bone Marrow Transplantation

Fig. 1: Impact of conditioning by FluMel and FluTreo on outcome.

From: Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

Fig. 1: Impact of conditioning by FluMel and FluTreo on outcome.

Cumulative incidences of a non-relapse mortality and b relapse by conditioning protocol are represented. Kaplan–Meier curves represent c leukemia-free survival and d overall survival by conditioning protocol. NRM non-relapse mortality; RI relapse incidence; LFS leukemia-free survival and OS overall survival; FluMel140 Fludarabine/Melphalan with a total dose 140 mg /m2; FluTreo42 Fludarabine/Treosulfan with a total dose of 42 g/m2.

Back to article page